Intermediate Results of the Prospective Randomized Controlled Trial VOG-01: "Evaluation of the Efficacy of Neoadjuvant Combination Hormone Therapy in Premenopausal Patients With ER+ HER2- Breast Cancer". Вопр. онкол. 2022, 68 (3), 354-361. https://doi.org/10.37469/0507-3758-2022-68-3-354-361.